Paris, France

Yi Shi

This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Sanofi. Active years: 2013-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi Shi. Retrieved from https://idiyas.com/inventor/yi-shi-fkwrm1wl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 33.3

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yi Shi: Innovator in Alzheimer's Disease Research

Introduction

Yi Shi is a prominent inventor based in Paris, France. He has made significant contributions to the field of Alzheimer's disease research. With a total of 3 patents, his work focuses on developing humanized antibodies that target specific forms of the beta-amyloid peptide.

Latest Patents

Yi Shi's latest patents include innovative humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide. These antibodies are crucial for advancing methods of treatment in Alzheimer's disease. The patents detail the use of these antibodies in therapeutic applications, aiming to improve patient outcomes.

Career Highlights

Yi Shi is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi allows him to collaborate with other experts in the field, enhancing the impact of his research. His dedication to innovation in biotechnology has positioned him as a key figure in the fight against Alzheimer's disease.

Collaborations

Some of Yi Shi's notable coworkers include Nicolas Baurin and Francis Blanche. Their collaborative efforts contribute to the advancement of research and development in the field of humanized antibodies.

Conclusion

Yi Shi's contributions to Alzheimer's disease research through his innovative patents and collaborations highlight his importance in the scientific community. His work continues to pave the way for new therapeutic approaches in combating this challenging disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…